Difference between revisions of "Prednisolone (Millipred)"
Jump to navigation
Jump to search
m (Text replacement - "http://chemocare.com/chemotherapy" to "https://chemocare.com/chemotherapy") |
m |
||
| Line 22: | Line 22: | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
| + | |||
| + | ==Diseases for which it was used== | ||
| + | *[[Acute myeloid leukemia - historical|Acute myeloid leukemia]] | ||
==Patient drug information== | ==Patient drug information== | ||
| Line 52: | Line 55: | ||
[[Category:Multiple myeloma medications]] | [[Category:Multiple myeloma medications]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
| + | |||
| + | [[Category:Acute myeloid leukemia medications (historic)]] | ||
[[Category:FDA approved in 1955]] | [[Category:FDA approved in 1955]] | ||
[[Category:PMDA approved drugs]] | [[Category:PMDA approved drugs]] | ||
[[Category:WHO Essential Cancer Medicine]] | [[Category:WHO Essential Cancer Medicine]] | ||
Revision as of 00:50, 29 April 2022
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2][3]
Route: PO, gtt (ophthalmic eye drops)
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Acquired coagulopathy
- B-cell acute lymphoblastic leukemia
- Burkitt lymphoma
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Extranodal NK- and T-cell lymphoma, nasal type
- Follicular lymphoma
- Hodgkin lymphoma
- Langerhans cell histiocytosis
- Mantle cell lymphoma
- Marginal zone lymphoma
- Multiple myeloma
- Prostate cancer
Diseases for which it was used
Patient drug information
- Prednisolone (Millipred) patient drug information (Chemocare)[4]
- Prednisolone (Millipred) patient drug information (UpToDate)[5]
Also known as
- Generic names: delta(1)hydrocortisone, delta1-dehydro-hydrocortisone, deltahydrocortisone, metacortandralone, prednisolone acetate, prednisolone tebutate
- Brand names: Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Cotolone, Dacortin H, Decaprednil, Decortin H, Delta-Cortef, Deltacortril, Delta-Diona, Delta-Phoricol, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Medicort, Meticortelone, Meti-derm, Millipred, Opredsone, Orapred, Panafcortelone, Predcor, Predicort, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Prednicortelone, Predni-Helvacort, Prelone, Prenilone, Pri-Cortin, Veripred
References
Categories:
- Drugs
- Oral medications
- Steroids
- Immunosuppressants
- Chronic lymphocytic leukemia medications
- Acquired coagulopathy medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Diffuse large B-cell lymphoma medications
- Extranodal NK- and T-cell lymphoma, nasal type medications
- Follicular lymphoma medications
- Hodgkin lymphoma medications
- Langerhans cell histiocytosis medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Multiple myeloma medications
- Prostate cancer medications
- Acute myeloid leukemia medications (historic)
- FDA approved in 1955
- PMDA approved drugs
- WHO Essential Cancer Medicine